skip to main content
select
select
select
DateCaseTitleExpertiseCounsel
Jan 2, 2020 2020 FC 1 Seedlings Life Sciences v Pfizer We successfully represented Pfizer in this patent infringement action. Seedlings – a non-practicing entity – alleged that Pfizer’...

Patents

Apr 10, 2018 Federal Court File Nos. T-598-17 through T-605-17 AbbVie Corporation et al v Samsung Bioepis Co. Ltd. We represented AbbVie in a series of eight applications under the PMNOC Regulations relating to AbbVie’s blockbuster drug HUMIRA.  The c...

Patents

Apr 9, 2018 Federal Court File No. T-1355-17 Samsung Bioepis Co., Ltd. v AbbVie Biotechnology Ltd. et al. We represented AbbVie in a patent impeachment action brought by Samsung Bioepis in relation to Samsung Bioepis’ biosimilar to AbbVIe’s ...

Patents

Feb 8, 2018 2018 FCA 33 Teva Canada Limited v. Janssen Inc. We successfully represented Janssen on Teva’s appeal from an award of damages and costs in respect of Teva’s infringement of the patent...

Patents

Nov 18, 2016 2016 ONSC 7151 Actavis Pharma Company v Alcon Canada Inc. et al. We obtained an order dismissing Actavis’ claims for monetary relief under the UK and Ontario Statutes of Monopolies, in an action for damage...

Patents

May 31, 2016 2016 FC 593 Janssen Inc. v. Teva Canada Limited We successfully represented Janssen in this action for damages resulting from infringement of the patent covering Janssen’s LEVAQUIN product....

Patents

© 2015 Belmore Neidrauer LLP | Legal Disclaimer | Privacy Policy